Pediatric brain tumor cancer stem cells: cell cycle dynamics, DNA repair, and etoposide extrusion. Hussein, D., Punjaruk, W., Storer, L. C. D., Shaw, L., Othman, R., Ottoman, R., Peet, A., Miller, S., Bandopadhyay, G., Heath, R., Kumari, R., Bowman, K. J., Braker, P., Rahman, R., Jones, G. D. D., Watson, S., Lowe, J., Kerr, I. D., Grundy, R. G., & Coyle, B. Neuro-Oncology, 13(1):70–83, January, 2011.
doi  abstract   bibtex   
Reliable model systems are needed to elucidate the role cancer stem cells (CSCs) play in pediatric brain tumor drug resistance. The majority of studies to date have focused on clinically distinct adult tumors and restricted tumor types. Here, the CSC component of 7 newly established primary pediatric cell lines (2 ependymomas, 2 medulloblastomas, 2 gliomas, and a CNS primitive neuroectodermal tumor) was thoroughly characterized. Comparison of DNA copy number with the original corresponding tumor demonstrated that genomic changes present in the original tumor, typical of that particular tumor type, were retained in culture. In each case, the CSC component was approximately 3-4-fold enriched in neurosphere culture compared with monolayer culture, and a higher capacity for multilineage differentiation was observed for neurosphere-derived cells. DNA content profiles of neurosphere-derived cells expressing the CSC marker nestin demonstrated the presence of cells in all phases of the cell cycle, indicating that not all CSCs are quiescent. Furthermore, neurosphere-derived cells demonstrated an increased resistance to etoposide compared with monolayer-derived cells, having lower initial DNA damage, potentially due to a combination of increased drug extrusion by ATP-binding cassette multidrug transporters and enhanced rates of DNA repair. Finally, orthotopic xenograft models reflecting the tumor of origin were established from these cell lines. In summary, these cell lines and the approach taken provide a robust model system that can be used to develop our understanding of the biology of CSCs in pediatric brain tumors and other cancer types and to preclinically test therapeutic agents.
@article{hussein_pediatric_2011,
	title = {Pediatric brain tumor cancer stem cells: cell cycle dynamics, {DNA} repair, and etoposide extrusion},
	volume = {13},
	issn = {1523-5866},
	shorttitle = {Pediatric brain tumor cancer stem cells},
	doi = {10.1093/neuonc/noq144},
	abstract = {Reliable model systems are needed to elucidate the role cancer stem cells (CSCs) play in pediatric brain tumor drug resistance. The majority of studies to date have focused on clinically distinct adult tumors and restricted tumor types. Here, the CSC component of 7 newly established primary pediatric cell lines (2 ependymomas, 2 medulloblastomas, 2 gliomas, and a CNS primitive neuroectodermal tumor) was thoroughly characterized. Comparison of DNA copy number with the original corresponding tumor demonstrated that genomic changes present in the original tumor, typical of that particular tumor type, were retained in culture. In each case, the CSC component was approximately 3-4-fold enriched in neurosphere culture compared with monolayer culture, and a higher capacity for multilineage differentiation was observed for neurosphere-derived cells. DNA content profiles of neurosphere-derived cells expressing the CSC marker nestin demonstrated the presence of cells in all phases of the cell cycle, indicating that not all CSCs are quiescent. Furthermore, neurosphere-derived cells demonstrated an increased resistance to etoposide compared with monolayer-derived cells, having lower initial DNA damage, potentially due to a combination of increased drug extrusion by ATP-binding cassette multidrug transporters and enhanced rates of DNA repair. Finally, orthotopic xenograft models reflecting the tumor of origin were established from these cell lines. In summary, these cell lines and the approach taken provide a robust model system that can be used to develop our understanding of the biology of CSCs in pediatric brain tumors and other cancer types and to preclinically test therapeutic agents.},
	language = {eng},
	number = {1},
	journal = {Neuro-Oncology},
	author = {Hussein, Deema and Punjaruk, Wiyada and Storer, Lisa C. D. and Shaw, Lucy and Othman, Ramadhan and Ottoman, Ramadan and Peet, Andrew and Miller, Suzanne and Bandopadhyay, Gagori and Heath, Rachel and Kumari, Rajendra and Bowman, Karen J. and Braker, Paul and Rahman, Ruman and Jones, George D. D. and Watson, Susan and Lowe, James and Kerr, Ian D. and Grundy, Richard G. and Coyle, Beth},
	month = jan,
	year = {2011},
	keywords = {Adolescent, Animals, Antineoplastic Agents, Phytogenic, Brain Neoplasms, Cell cycle, Child, Child, Preschool, Chromosome Aberrations, DNA Repair, Drug Resistance, Neoplasm, Etoposide, Glioblastoma, Humans, Mice, Neoplasm Recurrence, Local, Neoplastic Stem Cells, Polymorphism, Single Nucleotide, Tumor Cells, Cultured, Xenograft Model Antitumor Assays, comet assay},
	pages = {70--83},
}
Downloads: 0
About
Documentation
Keywords
Search
Users
Terms and Conditions of Use
Privacy Policy
Sitemap
© BibBase.org 2021